These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 29760214)

  • 1. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of specific sequence motif of YopN of Yersinia pseudotuberculosis required for systemic infection.
    Bamyaci S; Nordfelth R; Forsberg Å
    Virulence; 2019 Dec; 10(1):10-25. PubMed ID: 30488778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TyeA of Yersinia pseudotuberculosis is involved in regulation of Yop expression and is required for polarized translocation of Yop effectors.
    Sundberg L; Forsberg A
    Cell Microbiol; 2003 Mar; 5(3):187-202. PubMed ID: 12614462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis.
    Amer AA; Gurung JM; Costa TR; Ruuth K; Zavialov AV; Forsberg Å; Francis MS
    Front Cell Infect Microbiol; 2016; 6():66. PubMed ID: 27446813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.
    Amer AA; Costa TR; Farag SI; Avican U; Forsberg Å; Francis MS
    PLoS One; 2013; 8(10):e77767. PubMed ID: 24098594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis.
    Joseph SS; Plano GV
    Front Cell Infect Microbiol; 2013; 3():1. PubMed ID: 23355975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation of YopE and YopN into eukaryotic cells by Yersinia pestis yopN, tyeA, sycN, yscB and lcrG deletion mutants measured using a phosphorylatable peptide tag and phosphospecific antibodies.
    Day JB; Ferracci F; Plano GV
    Mol Microbiol; 2003 Feb; 47(3):807-23. PubMed ID: 12535078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TyeA, a protein involved in control of Yop release and in translocation of Yersinia Yop effectors.
    Iriarte M; Sory MP; Boland A; Boyd AP; Mills SD; Lambermont I; Cornelis GR
    EMBO J; 1998 Apr; 17(7):1907-18. PubMed ID: 9524114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of Yersinia pestis YopN mutants that constitutively block Yop secretion.
    Ferracci F; Schubot FD; Waugh DS; Plano GV
    Mol Microbiol; 2005 Aug; 57(4):970-87. PubMed ID: 16091038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gatekeeper of Yersinia type III secretion is under RNA thermometer control.
    Pienkoß S; Javadi S; Chaoprasid P; Nolte T; Twittenhoff C; Dersch P; Narberhaus F
    PLoS Pathog; 2021 Nov; 17(11):e1009650. PubMed ID: 34767606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type III secretion decreases bacterial and host survival following phagocytosis of Yersinia pseudotuberculosis by macrophages.
    Zhang Y; Murtha J; Roberts MA; Siegel RM; Bliska JB
    Infect Immun; 2008 Sep; 76(9):4299-310. PubMed ID: 18591234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YscB of Yersinia pestis functions as a specific chaperone for YopN.
    Jackson MW; Day JB; Plano GV
    J Bacteriol; 1998 Sep; 180(18):4912-21. PubMed ID: 9733695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia enterocolitica TyeA, an intracellular regulator of the type III machinery, is required for specific targeting of YopE, YopH, YopM, and YopN into the cytosol of eukaryotic cells.
    Cheng LW; Schneewind O
    J Bacteriol; 2000 Jun; 182(11):3183-90. PubMed ID: 10809698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.
    Håkansson S; Schesser K; Persson C; Galyov EE; Rosqvist R; Homblé F; Wolf-Watz H
    EMBO J; 1996 Nov; 15(21):5812-23. PubMed ID: 8918459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Yersinia Yop-effector delivery by translocated YopE.
    Aili M; Isaksson EL; Carlsson SE; Wolf-Watz H; Rosqvist R; Francis MS
    Int J Med Microbiol; 2008 Apr; 298(3-4):183-92. PubMed ID: 17597003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.